A novel medication decision gene signature predicts response to individualized therapy and prognosis outcomes in hepatocellular carcinoma patients
Ontology highlight
ABSTRACT: Molecular targeted therapy has shown potential in hepatocellular carcinoma (HCC) patients, and immunotherapy applications are developing rapidly. However, clinical guidance for making individualized therapy decisions for HCC patients remains lacking. To facilitate individualized and reasonable clinical guidance for each HCC patient, we constructed the MDH score.
ORGANISM(S): Homo sapiens
PROVIDER: GSE213615 | GEO | 2022/09/22
REPOSITORIES: GEO
ACCESS DATA